المؤلفون: Zhang, Hai-Tao, Huang, Ming-Xing, Liu, Xi, Zheng, Xin-Chun, Li, Xing-Hua, Chen, Gong-Qi, Xia, Jin-Yu, Hong, Zhong-Si

المصدر: American Journal of Chinese Medicine; 2020, Vol. 48 Issue 4, p779-792, 14p, 4 Charts

مصطلحات موضوعية: ANTIBIOTICS, THERAPEUTIC use of glucocorticoids, THERAPEUTIC use of immunoglobulins, THERAPEUTIC use of interferons, ACADEMIC medical centers, ANTIVIRAL agents, CHEST X rays, COMPUTED tomography, COUGH, DIARRHEA, FEVER, HERBAL medicine, MEDICINE, CHINESE medicine, RESEARCH funding, INTEGRATIVE medicine, TREATMENT effectiveness, RETROSPECTIVE studies, CASE-control method, LOPINAVIR-ritonavir, DESCRIPTIVE statistics, NUCLEIC acid amplification techniques, COVID-19, EVALUATION, THERAPEUTICS

مستخلص: Since the outbreak of Corona Virus Disease 2019 (COVID-19) in Hubei province, the epidemic scale has increased rapidly, and no effective antiviral drug therapy has been identified yet. This study aimed to evaluate the adjuvant efficacy of Natural Herbal Medicine (NHM) combined with Western medicine in the treatment of COVID-19. We performed a retrospective, 1:1 matched, case-control study of the first cohort of hospitalized COVID-19-confirmed cases (January 17, 2020 to January 28, 2020). A total of 22 of the 36 confirmed patients were included in this study, split into two groups of 11: the NHM group (NHM combined standard Western medicine treatment) and control group (standard Western medicine treatment alone). All patients received appropriate supportive care and regular clinical and laboratory monitoring. Main evaluation indicators included improvement of clinical symptoms such as fever, cough and diarrhea after hospitalization; pathogen nucleic acid test result of respiratory tract and fecal specimens of the patient after hospitalization, and change of chest CT examination after hospitalization. The duration of fever in the NHM group (3. 4 ± 2. 4 days) was significantly shorter than that in the control group (5. 6 ± 2. 2 days) (p = 0. 0 3). During the whole hospitalization period, the number of cases with diarrhea in the NHM group (two cases) was less than that in the control group (eight cases) (p = 0. 0 3). Compared with the control group (7. 5 ± 1. 6), the duration for improvement (DI) of chest CT in the NHM group (5. 6 ± 2. 3) was significantly shorter (p = 0. 0 4). Our results suggest that NHM could improve the clinical symptoms of COVID-19 patients and may be effective in treating COVID-19; thus, a larger, prospective, randomized, controlled clinical trial should be conducted to further evaluate the adjuvant efficacy of NHM in the treatment of COVID-19. [ABSTRACT FROM AUTHOR]

: Copyright of American Journal of Chinese Medicine is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Cramer, Holger

المصدر: Journal of Integrative & Complementary Medicine; Feb2022, Vol. 28 Issue 2, p108-109, 2p

مصطلحات موضوعية: MENTAL illness treatment, MENTAL illness prevention, MENTAL illness risk factors, COVID-19, INTEGRATIVE medicine, MENTAL health, COVID-19 pandemic, COMORBIDITY

مستخلص: The article presents the discussion on mental health before, during, and after COVID-19. Topics include prevalence of mental disorders, of anxiety, depression, and post-traumatic stress disorder being on the rise; and prevalence of mental disorders especially depression increasing significantly with the onset of the pandemic.

المصدر: NewsRx COVID-19 Weekly; 4/14/2023, p18-18, 1p

مصطلحات موضوعية: SARS-CoV-2, SOCIAL media, COVID-19

المؤلفون: Zeng, Yong, Zhang, Bo, Zhang, Xufeng, Yi, Cunjian

المصدر: Chinese Medicine; 5/14/2020, Vol. 15 Issue 1, p1-3, 3p

مصطلحات موضوعية: PNEUMONIA prevention, PNEUMONIA treatment, CANCER patients, CATASTROPHIC illness, CHEST X rays, COMPUTED tomography, INTENSIVE care units, MEDICINE, CHINESE medicine, TUMORS, COMORBIDITY, SYMPTOMS, INTEGRATIVE medicine, DISCHARGE planning, TREATMENT effectiveness, SEVERITY of illness index, DISEASE progression, FIBRIN fibrinogen degradation products, COVID-19

مستخلص: In December 2019, a cluster of pneumonia cases was caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China. Cancer patients are a special group, the immunity of them will be suppressed because of various anti-tumor treatments, and the risk of infection will be greatly increased, so we will report clinical features of 9 cancer patients with SARS-CoV-2 infection. 5 (56%) patients were ordinary type, 3 (33%) were severe type, and 1 (11%) was critical type. A total of 8 patients received combined therapy of traditional Chinese medicines and western medicines. From the clinical outcomes of these 8 patients, western combined therapy of traditional Chinese medicine was indeed an effective treatment method. D-dimmer rise, infection index rise, and chest CT(computed tomography) progression may be clinical warning indicators for severe patients, in our study, more 50% of patients had elevated levels of these indicators, but only 44% (including the dead) of patients had received treatment in the intensive care unit. 5 (56%) ordinary type patients had been discharged, while the 1 (11%) critical type patient died 3 days after admission. Cancer comorbidity seems to have no direct relationship with severe events, and the combination of traditional Chinese medicine and western medicine may be effective in the prevention and treatment of novel coronavirus-infected pneumonia (NICP). [ABSTRACT FROM AUTHOR]

: Copyright of Chinese Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المصدر: Health & Medicine Week; 3/10/2023, p2388-2388, 1p

مصطلحات موضوعية: CORONAVIRUSES, NURSING services, INTEGRATIVE medicine, COVID-19, MERS coronavirus

مستخلص: According to news originating from Seoul, South Korea, by NewsRx correspondents, research stated, "This study aimed to analyse the policy formation process of South Korean Integrated Nursing Care Service System (INCSS). Keywords: Seoul; South Korea; Asia; Coronavirus; Health and Medicine; Nursing Care; Patient Care; RNA Viruses; Risk and Prevention; Viral; Virology EN Seoul South Korea Asia Coronavirus Health and Medicine Nursing Care Patient Care RNA Viruses Risk and Prevention Viral Virology 2388 2388 1 03/23/23 20230310 NES 230310 2023 MAR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on RNA Viruses - Coronavirus. [Extracted from the article]

: Copyright of Health & Medicine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Zhong, Nan-shan, Yang, Zi-feng, Jiang, Mei, Liang, Jing-yi

المصدر: Chinese Journal of Integrative Medicine; 2020, Vol. 26 Issue 11, p803-804, 2p

مصطلحات موضوعية: DRUG efficacy, HERBAL medicine, CHINESE medicine, ADULT respiratory distress syndrome, INTEGRATIVE medicine, INVESTIGATIONAL drugs, COVID-19, EVALUATION, THERAPEUTICS

المؤلفون: Vaidya, Ashok D. B.

المصدر: Indian Practitioner; Aug2020, Vol. 73 Issue 8, p7-8, 2p

مصطلحات موضوعية: MEDICAL care, COVID-19 pandemic, TRADITIONAL medicine, INTEGRATIVE medicine, NATURAL immunity

مستخلص: COVID-19 pandemic has clearly shown lack of global readiness to address such an emergency with efficacy. The variability of decision making of how to tackle the problem, in different nations, has led to a wide disparity in the rates of morbidity and mortality. The conventional modalities of controlling the pandemic have often failed. As a consequence, the need to rethink about healthcare systems has emerged. Openness is perceived, for the first time, to explore traditional medicine to enhance innate immunity and to increase disease-resistance against viral-epidemics. The younger generation has a broader global and trans-cultural appreciation of health care. It is suggested that there is a need to grab the initiative to conduct integrative health-care research by state-of-the-art scientific methods. Such research would include valid experiential and observational data rather than merely emphasizing double-blind controlled trials. [ABSTRACT FROM AUTHOR]

: Copyright of Indian Practitioner is the property of Indian Practitioner and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Ng, Jeremy Y.

المصدر: BMC Complementary Medicine & Therapies; 11/23/2020, Vol. 20 Issue 1, pN.PAG-N.PAG, 1p, 2 Diagrams, 3 Charts, 1 Graph

مصطلحات موضوعية: ALTERNATIVE medicine, BIBLIOMETRICS, MEDICAL research, TRADITIONAL medicine, INTEGRATIVE medicine, COVID-19 pandemic

مستخلص: Background: Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2, and responsible for a global pandemic. Despite there being no known vaccines or medicines that prevent or cure COVID-19, many traditional, integrative, complementary and alternative medicines (TICAMs) have been touted as the solution, as well as researched as a potential remedy globally. This study presents a bibliometric analysis of global research trends at the intersection of TICAM and COVID-19. Methods: SCOPUS, MEDLINE, EMBASE, AMED and PSYCINFO databases were searched on July 5, 2020, with results being exported on the same day. All publication types were included, however, articles were only deemed eligible if they made mention of one or more TICAMs for the potential prevention, treatment, and/or management of COVID-19 or a health issue indirectly resulting from the COVID-19 pandemic. The following eligible article characteristics were extracted: title; author names, affiliations, and countries; DOI; publication language; publication type; publication year; journal (and whether it is TICAM-focused); 2019 impact factor, and TICAMs mentioned. Results: A total of 296 eligible articles were published by 1373 unique authors at 977 affiliations across 56 countries. The most common countries associated with author affiliation included China, the United States, India and Italy. The vast majority of articles were published in English, followed by Chinese. Eligible articles were published across 157 journals, of which 33 were TICAM-focused; a total of 120 journals had a 2019 impact factor, which ranged from 0.17 to 60.392. A total of 327 TICAMs were mentioned across eligible articles, with the most common ones including: traditional Chinese medicine (n = 94), vitamin D (n = 67), melatonin (n = 16), phytochemicals (n = 12), and general herbal medicine (n = 11). Conclusions: This study provides researchers and clinicians with a greater knowledge of the characteristics of articles that been published globally at the intersection of COVID-19 and TICAM to date. At a time where safe and effective vaccines and medicines for the prevention and treatment of COVID-19 have yet to be discovered, this study provides a current snapshot of the quantity and characteristics of articles written at the intersection of TICAM therapies and COVID-19. [ABSTRACT FROM AUTHOR]

: Copyright of BMC Complementary Medicine & Therapies is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Kuang, Zhuoran, Li, Xiaoyan, Cai, Jianxiong, Chen, Yaolong, Qiu, Xiaoyuan, Ni, Xiaojia, Evidence-based Traditional and Integrative Medicine Working Group for Public Health Emergency

المصدر: Trials; 4/7/2021, Vol. 22 Issue 1, p1-3, 3p, 2 Diagrams

مصطلحات موضوعية: HEALTH surveys, CHINESE medicine, COVID-19, RECORDING & registration, SARS disease, H1N1 influenza

مستخلص: An amendment to this paper has been published and can be accessed via the original article. [ABSTRACT FROM AUTHOR]

: Copyright of Trials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Kuang, Zhuoran, Li, Xiaoyan, Cai, Jianxiong, Chen, Yaolong, Qiu, Xiaoyuan, Ni, Xiaojia, Evidence-based Traditional and Integrative Medicine Working Group for Public Health Emergency

المصدر: Trials; 3/5/2021, Vol. 22 Issue 1, p1-11, 11p, 1 Diagram, 4 Charts

مصطلحات موضوعية: CHINESE medicine, HEALTH surveys, COVID-19, CLINICAL trial registries, EMERGENCY medical services communication systems, H1N1 influenza

مستخلص: Objective: To assess the registration quality of traditional Chinese medicine (TCM) clinical trials for COVID-19, H1N1, and SARS.Method: We searched for clinical trial registrations of TCM in the WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) on April 30, 2020. The registration quality assessment is based on the WHO Trial Registration Data Set (Version 1.3.1) and extra items for TCM information, including TCM background, theoretical origin, specific diagnosis criteria, description of intervention, and outcomes.Results: A total of 136 records were examined, including 129 severe acute respiratory syndrome coronavirus 2 (COVID-19) and 7 H1N1 influenza (H1N1) patients. The deficiencies in the registration of TCM clinical trials (CTs) mainly focus on a low percentage reporting detailed information about interventions (46.6%), primary outcome(s) (37.7%), and key secondary outcome(s) (18.4%) and a lack of summary result (0%). For the TCM items, none of the clinical trial registrations reported the TCM background and rationale; only 6.6% provided the TCM diagnosis criteria or a description of the TCM intervention; and 27.9% provided TCM outcome(s).Conclusion: Overall, although the number of registrations of TCM CTs increased, the registration quality was low. The registration quality of TCM CTs should be improved by more detailed reporting of interventions and outcomes, TCM-specific information, and sharing of the result data. [ABSTRACT FROM AUTHOR]

: Copyright of Trials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)